Views

All Case Studies Views Resources Whitepapers Podcasts On-Demand Webinars
Rare Diseases: Why Lexicon Matters
I often find myself cringing when I use the industry-accepted word “rare” to describe a condition or disease. As a patient advocate, I find this term to be insensitive, misleading, and at times even a little cruel.
View Aug 26, 2019
Insights From The New Product Planning Panel
At the end of last year, Clarion led a panel discussion entitled, Lessons From Emerging Biopharma Companies Commercializing Their First Asset at ExL Pharma’s 3rd New Product Planning (NPP) Summit.
View May 6, 2019
Seize the Day
The multiple forces dramatically reshaping the healthcare industry show no sign of abating.
View Sep 21, 2018